Donald G. Morris

1.7k citations

48 papers · 1.3k indexed · h-index 17

Co-authors: Peter Forsyth Dylan R. Edwards Douglas A. Stewart Kevin J. Leco Garnette Sutherland Huong Muzik A Chaudhry Stefan Glück
Topics: Hematopoietic Stem Cell Transplantation (7 papers)Virus-based gene therapy research (5 papers)Lung Cancer Treatments and Mutations (4 papers)
Cited by: Hematology Transplantation Cancer Research
Journals: The Journal of Experimental Medicine Journal of Clinical Oncology Blood
Partner nations: Canada United States Japan

In The Last Decade

Donald G. Morris

47 papers receiving 1.3k citations

Peers

Countries citing papers authored by Donald G. Morris

Since Specialization

Citations

This map shows the geographic impact of Donald G. Morris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Donald G. Morris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Donald G. Morris more than expected).

Fields of papers citing papers by Donald G. Morris

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Donald G. Morris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Donald G. Morris. The network helps show where Donald G. Morris may publish in the future.

Co-authorship network of co-authors of Donald G. Morris

This figure shows the co-authorship network connecting the top 25 collaborators of Donald G. Morris. A scholar is included among the top collaborators of Donald G. Morris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Donald G. Morris. Donald G. Morris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Abstract P1-08-01: Validation of automated Ki67 analysis to predict Oncotype DX recurrence score in early-stage breast cancer 2022 ·Cancer Research ·(unknown),Tasnima Abedin,Satbir Thakur,Haocheng Li,(unknown),Emeka K. Enwere,Sasha Lupichuk,Nancy Nixon,Donald G. Morris,Hua Yang,Paola Neri	1
2	425P The impact of obesity on treatment outcomes in patients with solid tumour malignancies treated with first-line (1L) immuno-oncology (IO) agents 2020 ·Annals of Oncology ·Gan Chen,Daniel E. Meyers,Igor Stukalin,Shaan Dudani,(unknown),(unknown),(unknown),(unknown),(unknown),(unknown),Aliyah Pabani,Timothy Cheng,Takeshi Yuasa,Donald G. Morris,Ravindran Kanesvaran,Sumanta K. Pal,Lori Wood,Frede Donskov,Toni K. Choueiri,D.Y.C. Heng	2
3	Repurposing Sunitinib with Oncolytic Reovirus as a Novel Immunotherapeutic Strategy for Renal Cell Carcinoma 2016 ·Clinical Cancer Research ·Keith A. Lawson,Ahmed Mostafa,Zhong Qiao Shi,Jason Spurrell,Wenqian Chen,Jun Kawakami,Kathy Gratton,Satbir Thakur,Donald G. Morris	31
4	DATA COLLECTION, PROCESSING, VALIDATION, AND VERIFICATION 2008 ·Health Physics ·Deborah L. Martin,(unknown),(unknown),(unknown),(unknown),(unknown),Donald G. Morris,(unknown),(unknown)	6
5	Adult Recipients of Matched Related Donor Blood Cell Transplants Given Myeloablative Regimens Including Pretransplant Antithymocyte Globulin Have Lower Mortality Related to Graft-versus-Host Disease: A Matched Pair Analysis 2007 ·Biology of Blood and Marrow Transplantation ·James A. Russell,A. Robert Turner,Loree Larratt,Ahsan Chaudhry,Donald G. Morris,Christopher Brown,Diana Quinlan,Douglas A. Stewart	61
6	Upfront double high-dose chemotherapy with DICEP followed by BEAM and autologous stem cell transplantation for poor-prognosis aggressive non-Hodgkin lymphoma 2006 ·Blood ·Douglas A. Stewart,Nizar J. Bahlis,Karen Valentine,Alex Balogh,Lynn Savoie,Donald G. Morris,(unknown),Chris Brown,James A. Russell	21
7	Pharmacogenetic profiling in azathioprine treatment: TPMT, ITPA, and MTHFR polymorphisms and toxicity 2004 ·Gastroenterology ·Azhar Ansari,M Arenas,(unknown),Donald G. Morris,S Greenfield,(unknown),(unknown),Lynette D. Fairbanks,(unknown),J. A. Duley,J Sanderson,(unknown)	1
8	Gastrointestinal Stromal Tumours: Etiology, Pathology and Clinical Management 2004 ·Canadian Journal of Gastroenterology and Hepatology ·Martin E. Blackstein,Pierre Dubé,Jonathan A. Fletcher,(unknown),Margaret A. Knowling,Richard Létourneau,Donald G. Morris,Robert H. Riddell,(unknown),Carol J. Swallow	9
9	Micrometastases in apheresis products predict shorter progression-free and overall survival in patients with breast cancer undergoing high-dose chemotherapy (HDCT) and autologous blood stem cell transplantation (ABSCT) 2003 ·Bone Marrow Transplantation ·Rachel Syme,Doug Stewart,(unknown),Joanne Luider,(unknown),John S. Klassen,Donald G. Morris,CB Brown,Jeffrey A. Russell,Stefan Glück	10
10	Once-daily intravenous busulfan given with fludarabine as conditioning for allogeneic stem cell transplantation: Study of pharmacokinetics and early clinical outcomes 2002 ·Biology of Blood and Marrow Transplantation ·Jeffrey A. Russell,Hai T. Tran,Diana Quinlan,A Chaudhry,Peter Duggan,Chris Brown,Douglas A. Stewart,Joseph D. Ruether,Donald G. Morris,Stefan Glück,(unknown),Börje S. Andersson	220
11	Unrelated donor BMT recipients given pretransplant low-dose antithymocyte globulin have outcomes equivalent to matched sibling BMT: a matched pair analysis 2002 ·Bone Marrow Transplantation ·Peter Duggan,Karen Booth,A Chaudhry,Douglas A. Stewart,(unknown),Samuel Gluck,Donald G. Morris,(unknown),(unknown),Max J. Coppes,Richard A. Anderson,Johannes Wolff,Maarten Egeler,Sapan S. Desai,(unknown),Loree Larratt,(unknown),(unknown),(unknown)	55
12	Reovirus induces apoptosis in breast and prostate cell lines and activates Nf-kappaB in the nucleus Implications for a prognostic factor in successful reovirus therapy 2001 ·Chandini M. Thirukkumaran,Joanne Luider,(unknown),Patrick Lee,Donald G. Morris	2
13	Accurate data redistribution cost estimation in software distributed shared memory systems 2001 ·ACM SIGPLAN Notices ·Donald G. Morris,David K. Lowenthal	2
14	The CD3−16+56+ NK cell count independently predicts autologous blood stem cell mobilization 2001 ·Bone Marrow Transplantation ·D. A. Stewart,Dan Guo,Joanne Luider,Iwona Auer,John S. Klassen,Donald G. Morris,CB Brown,A Chaudhry,Stefan Glück,JA Russell	5
15	Predictive factors for long-term engraftment of autologous blood stem cells 2000 ·Bone Marrow Transplantation ·(unknown),Dan Guo,Joanne Luider,Iwona Auer,John S. Klassen,A Chaudhry,Donald G. Morris,Stefan Glück,CB Brown,JA Russell,D. A. Stewart	26
16	Double high-dose therapy for Hodgkin's disease with dose-intensive cyclophosphamide, etoposide, and cisplatin (DICEP) prior to high-dose melphalan and autologous stem cell transplantation 2000 ·Bone Marrow Transplantation ·(unknown),Dan Guo,Stefan Glück,Donald G. Morris,A Chaudhry,(unknown),John S. Klassen,CB Brown,JA Russell	16
17	Superior autologous blood stem cell mobilization from dose-intensive cyclophosphamide, etoposide, cisplatin plus G-CSF than from less intensive chemotherapy regimens 1999 ·Bone Marrow Transplantation ·(unknown),Dan Guo,Donald G. Morris,MC Poon,(unknown),A. R. Jones,John S. Klassen,Iwona Auer,Joanne Luider,A Chaudhry,Chris Brown,JA Russell	43
18	Lymphoproliferative disease of 'lak cell' precursor large granular lymphocytes in association with celiac disease 1993 ·American Journal of Hematology ·Pamela Aranda Lopez,Donald G. Morris,P. R. Galbraith,David Lillicrap,Hugh F. Pross	4
19	Studies of lymphokine-activated killer (LAK) cells. I. Evidence using novel monoclonal antibodies that most human LAK precursor cells share a common surface marker. 1989 ·The Journal of Experimental Medicine ·Donald G. Morris,Hugh F. Pross	17
20	Characterization of acoustic emission from thermally-cycled lithium hydride 1988 ·(unknown),Donald G. Morris	1

About Donald G. Morris

Donald G. Morris is a scholar working on Transplantation, Hematology and Oncology, having authored 48 papers that have together received 1.3k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (7 papers), Virus-based gene therapy research (5 papers) and Lung Cancer Treatments and Mutations (4 papers). The work is most often cited by research in Hematology (426 citations), Transplantation (63 citations) and Cancer Research (340 citations). Donald G. Morris has collaborated with scholars based in Canada, United States and Japan. Frequent co-authors include Peter Forsyth, Dylan R. Edwards, Douglas A. Stewart, Kevin J. Leco, Garnette Sutherland, Huong Muzik, A Chaudhry, Stefan Glück, Diana Quinlan and Penny Brasher. Their work appears in journals such as The Journal of Experimental Medicine, Journal of Clinical Oncology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact